Brief: G1 Therapeutics Q3 product sales USD 10.839 million
01/11/2023 10:41
Nov 1 (Reuters) - G1 Therapeutics Q3 product sales USD 10.839 million vs. IBES estimate USD 14.2 million. * Q3 operating expenses USD 28.668 million * Q3 pretax profit USD -17.299 million * Q3 net income USD -18.204 million * Q3 basic EPS USD -0.35
Recent news on G1 Therapeutics
See all newsG1 Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney
U.S. STOCKS ON THE MOVE-Walt Disney, SpringWorks, Shopify